Management ofIgA nephropathy: Evidence-based recommenglomerular diseases, whereas in Europe, it has been redations. The condition known as IgA nephropathy was first ported in 10 to 30% of glomerular disease series [8]. In identified when Berger observed mesangial staining for IgA in the United States, the overall prevalence is approxihealthy patients with isolated hematuria. These patients often mately 10 to 15% [9], although in specific groups such presented with recurrent synpharyngitic hematuria or less freas the American Indians in the Southwest, the rate is quently with asymptomatic microscopic hematuria and proteinuria. Although initially considered benign, we now recognize 35% [10]. IgAN is uncommon in blacks, whether they it as a common cause of end-stage renal failure. The overall live in the United States or in Africa [11, 12]. prognosis may be better than suggested in the literature, as Recurrence of IgAN after transplantation [13], evipatients with mild asymptomatic hematuria are often not biopdence showing that IgA glomerular deposits disappear in sied and, therefore, frequently are not included in published a kidney from an IgA donor [14], and IgA deposits obarticles. We reviewed prospective and retrospective adult studies published after 1976 and analyzed them to produce evidenceserved in other organs such as skin, lungs [15], or intesbased recommendations. Patients with proteinuria over 3 g/day,
This study confirms that arrest codes occur more frequently on Mondays and Tuesdays in a haemodialysis unit. Survival after an arrest code appears to be better than in certain other circumstances, probably in part because of the presence of witness, physician and equipment, and vascular access being readily available.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.